BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2021 Financial Results and Corporate Update

  Ultragenyx Pharmaceutical Inc. today announced that it will host a conference call on Thursday, February 10, 2022, at 5:00 pm ET to discuss its financial results and corporate update for the fourth quarter and the year ended December 31, 2021.

  February 3, 2022

   · 

  1 min read
• Business

  Avantor® Reports Fourth Quarter and Full-Year 2021 Results

  Avantor, Inc. today reported financial results for the fourth quarter and year ended December 31, 2021.

  February 3, 2022

   · 

  20 min read
• BioForest

  Gilead Sciences to Present at Upcoming Investor Conferences - Feb 03, 2022

  Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences.

  February 3, 2022

   · 

  1 min read
• JCR Pharmaceuticals to Present at the 18th Annual WORLDSymposiumTM 2022

  JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that it will present six posters at the 18th Annual WORLDSymposiumTM 2022, to be held February 7-11, 2022 in San Diego, Calif.

  February 3, 2022

   · 

  11 min read
• Biotech Bay

  Spruce Biosciences to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

  Spruce Biosciences, Inc. (Nasdaq: SPRB), today announced that Javier Szwarcberg, M.D., MPH, Chief Executive Officer, and Samir Gharib, President and Chief Financial Officer, will participate in a virtual fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference.

  February 3, 2022

   · 

  1 min read
• BioForest

  Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

  Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), today announced that Silverback management will participate in the SVB Leerink 11th Annual Global Healthcare Conference.

  February 3, 2022

   · 

  1 min read
• Deals

  Sierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

  Sierra Oncology, Inc today announced that the underwriters of its previously announced underwritten public offering exercised in full their option to purchase 750,000 additional shares of common stock at a price of $27.00 per share.

  February 3, 2022

   · 

  2 min read
• Medtronic continuous glucose monitoring to be reimbursed for eligible Alberta youth living with diabetes

  Medtronic Canada ULC, a subsidiary of Medtronic plc, a global leader in healthcare technology, applauds the Alberta government’s announcement of a comprehensive reimbursement program for continuous glucose monitoring for eligible residents living with diabetes, under the age of 18.

  February 3, 2022

   · 

  4 min read
• Pharm Country

  Arvinas to Present at Upcoming Investor Conferences - Feb 03, 2022

  Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that it will participate in two upcoming virtual investor conferences.

  February 3, 2022

   · 

  1 min read
• Genetown

  Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences - Feb 03, 2022

  Monte Rosa Therapeutics, Inc., a biotechnology company developing novel molecular glue degrader medicines, announced that the company is scheduled to present at the following upcoming investor conferences:

  February 3, 2022

   · 

  1 min read